Ready to start your GLP-1 journey with real support
CrossRef The transition from NAFLD to MASLD: implications for Diagnosis, Prognosis, and Clinical Management Carlo Acierno, Riccardo Nevola, Fannia Barletta, Katarzyna Zieliska, Luca Rinaldi, Ferdinando Carlo Sasso, Caterina Conte, Luigi Elio Adinolfi, Alfredo Caturano Exploration of Medicine .2025;[Epub] CrossRef The effects of salvia hispanica (chia seeds) on insulin sensitivity, hematological inflammatory indices and liver function in obese patients with non-alcoholic fatty liver disease (NAFLD) Sara Arefhosseini, Maryam Parimi, Helda Tutunchi, Mehrangiz Ebrahimi-Mameghani Nutrition & Metabolism .2025;[Epub] CrossRef Prevalence and Risk Factors of Metabolic DysfunctionAssociated Steatotic Liver Disease in Patients With Type 2 Diabetes Mellitus at a Tertiary Center in Saudi Arabia: Cross-Sectional Questionnaire Study Abdulrahman M Elnasieh, Mohammed Almesned, Akram N Al Hazmi, Atheer Alturki, Faisal I Alhawaidi, Razan K Alhadlq, Maryam Alramadhan, Nasser Alobilan, Yasser Sheikh Qroosh JMIR Diabetes .2025
Manganese plays different roles
Peptide Therapy Targeted therapies designed to repair, restore, and optimize your body from within Sermorelin Stimulates natural hormone growth to support energy, muscle recovery, fat loss, and better sleep
Retatrutides glucagon component adds another consideration
Few, if any, large, randomized clinical trials exist for these supplements specifically targeting GLP-1 in humans
